Developer docs
API playgroundTry for free, no card

Search company profiles

Stratis Group

Full company profile

uuid000al2q

Namestring
Stratis Group
Legal namestring
Stratis Group
Websiteurl
stratisgrp.com
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Stratis Group is a US-based consulting firm specializing in primary research, analytics, and strategic advisory services for the pharmaceutical, biotechnology, and academic industries. Headquartered in Palm Beach Gardens, Florida, the company delivers a portfolio of five core service offerings: commercialization strategy, market access optimization, advanced analytics, forecasting, and patient support program design. Its work targets enterprise clients — primarily pharmaceutical manufacturers, biotechnology companies, and physician networks — that face increasing complexity around drug pricing, payer coverage, and patient access as therapies move toward commercialization.

The company's "technology" is positioned as advanced analytics and forecasting capabilities, applied through a consultative engagement model rather than as a unified software platform. Its value proposition rests on domain specialization in life sciences market access and the integration of analytics with patient support program design, reimbursement strategy, and commercialization planning. Pricing is not publicly disclosed; services are understood to be delivered on a project-by-project or retainer basis typical of professional services firms.

In March 2026, Stratis Group was acquired by Nexus Health, part of The Lockwood Group, which is owned by Ares Management Corporation. The transaction combined Stratis's analytics, forecasting, and patient support capabilities with Nexus Health's medical affairs, oncology education, and access strategy offerings, with Clearsight Advisors acting as financial advisor. Post-acquisition, Stratis operates as a subsidiary within a PE-backed healthcare consulting platform.

Short descriptiontext

Stratis Group is a Florida-based healthcare consulting firm providing commercialization strategy, market access optimization, advanced analytics, forecasting, and patient support program services to pharmaceutical manufacturers, biotechnology companies, and physician networks. It was acquired by Nexus Health in March 2026.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersPalm Beach Gardens, United States
HQ citystring
Palm Beach Gardens
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical consulting services, market access strategy, commercialization analytics, life sciences consulting, patient support programs
SIC code1 code
  • Services-Management Consulting Services8742
Product category
Healthcare Consulting
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Strategic Consulting Services
TypeProfessional Services
Description

Revenue generated from providing commercialization strategy, market access optimization, and analytics consulting services to pharmaceutical, biotechnology, and physician network clients

pulse2.com
Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Stratis Group is a healthcare and life sciences consulting firm that delivers commercialization strategy, market access, advanced analytics, forecasting, and patient support program advisory services to pharmaceutical manufacturers, biotechnology companies, and physician networks. Engagements focus on helping clients navigate drug pricing, coverage, and patient access complexity as therapies move toward commercialization.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Enhanced capabilities in healthcare services and market access through strategic acquisition
Product overview1 text field

Stratis Group is a healthcare consulting firm offering a portfolio of advisory services for the life sciences industry. The company provides commercialization strategy, market access optimization, advanced analytics, forecasting, and patient support program services to pharmaceutical, biotechnology, and physician network clients. Rather than a unified software platform, Stratis Group delivers these as discrete consulting service offerings focused on helping clients navigate drug pricing complexity, coverage decisions, and patient access challenges during therapy commercialization.

Product and service5 records
1Commercialization Strategy Services
CategoryCommercialization consulting
Description

Consulting services helping pharmaceutical, biotechnology, and physician network clients develop and execute go-to-market strategies for their products.

2Market Access Services
CategoryMarket access consulting
Description

Advisory services focused on optimizing market access, reimbursement strategy, and payer negotiations for life sciences products.

3Advanced Analytics
CategoryAnalytics consulting
Description

Data analytics offerings providing insights for pharmaceutical commercialization, forecasting, and market opportunity assessment.

4Patient Support Programs
CategoryPatient services consulting
Description

Program design and optimization services for patient support initiatives to improve therapy access and adherence.

5Forecasting Services
CategoryForecasting consulting
Description

Market forecasting and predictive analytics services to support commercial planning and investment decisions.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-19
Description

The Lockwood Group, owned by Ares Management Corporation, acquired Stratis Group through its Nexus Health subsidiary as part of a broader growth strategy to expand its commercialization and market access platform across the life sciences industry.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-17
Description

Nexus Health, a strategic consulting and market access firm and part of The Lockwood Group, acquired Stratis Group. The acquisition combines Stratis Group's expertise in advanced analytics, forecasting, patient support programs, and market access optimization with Nexus Health's existing capabilities in medical affairs, oncology education, and access strategy.

Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
1Apex Market Access
TypeDirect peer
Description

Boutique consultancy focused on market access strategy and payer engagement for pharma and biotech. Comparable to Stratis in service scope and target client profile.

TypeBroad incumbent
Description

Largest life sciences commercial and clinical services firm. Overlaps with Stratis in pharma market access, commercialization analytics, and forecasting, but operates at vastly greater scale across the full drug development lifecycle.

3ZS Associates
TypeDirect peer
Description

Specialist consultancy focused on pharma sales, marketing, and market access analytics. Directly comparable to Stratis in offering advanced analytics and commercialization strategy for pharmaceutical manufacturers.

TypeDirect peer
Description

Boutique life sciences consultancy serving pharma and biotech on commercialization, market access, and advanced analytics. Closest direct competitor to Stratis in size, service mix, and target customer profile.

TypeDirect peer
Description

Specialized commercialization and market access services for biotech and pharma. Highly comparable to Stratis in patient support programs, market access strategy, and commercial analytics offerings.

TypeDirect peer
Description

Market access, health economics, and outcomes research consultancy serving biopharma. Overlaps with Stratis's reimbursement strategy, market access, and commercialization analytics services.

TypeBroad incumbent
Description

Large CRO with a commercial solutions practice covering market access, patient support, and commercialization strategy. Broader portfolio than Stratis but directly overlapping in pharma commercialization services.

TypeEmerging player
Description

Life sciences consulting and analytics firm serving pharma and biotech clients. Comparable in offering strategy and analytics services to specialty pharma clients.

TypeBroad incumbent
Description

Big Four consultancy with a dedicated life sciences practice covering market access, commercial strategy, and analytics. Represents scaled-incumbent competition for boutique players like Stratis.

TypeBroad incumbent
Description

Global strategy firm with a large pharma practice covering market access, commercial excellence, and analytics. Represents top-tier competition for Stratis's commercialization and pricing strategy engagements.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Stratis Group

Healthcare Consultingstratisgrp.com

Stratis Group is a Florida-based healthcare consulting firm providing commercialization strategy, market access optimization, advanced analytics, forecasting, and patient support program services to pharmaceutical manufacturers, biotechnology companies, and physician networks. It was acquired by Nexus Health in March 2026.

What Stratis Group does

Stratis Group is a US-based consulting firm specializing in primary research, analytics, and strategic advisory services for the pharmaceutical, biotechnology, and academic industries. Headquartered in Palm Beach Gardens, Florida, the company delivers a portfolio of five core service offerings: commercialization strategy, market access optimization, advanced analytics, forecasting, and patient support program design. Its work targets enterprise clients — primarily pharmaceutical manufacturers, biotechnology companies, and physician networks — that face increasing complexity around drug pricing, payer coverage, and patient access as therapies move toward commercialization.

The company's "technology" is positioned as advanced analytics and forecasting capabilities, applied through a consultative engagement model rather than as a unified software platform. Its value proposition rests on domain specialization in life sciences market access and the integration of analytics with patient support program design, reimbursement strategy, and commercialization planning. Pricing is not publicly disclosed; services are understood to be delivered on a project-by-project or retainer basis typical of professional services firms.

In March 2026, Stratis Group was acquired by Nexus Health, part of The Lockwood Group, which is owned by Ares Management Corporation. The transaction combined Stratis's analytics, forecasting, and patient support capabilities with Nexus Health's medical affairs, oncology education, and access strategy offerings, with Clearsight Advisors acting as financial advisor. Post-acquisition, Stratis operates as a subsidiary within a PE-backed healthcare consulting platform.

Stratis Group firmographics

Firmographics
Name
Stratis Group
Legal name
Stratis Group
Website
https://stratisgrp.com
Company type
Private
Operating status
Acquired
Headcount range
51–100 employees
Short description
Stratis Group is a Florida-based healthcare consulting firm providing commercialization strategy, market access optimization, advanced analytics, forecasting, and patient support program services to pharmaceutical manufacturers, biotechnology companies, and physician networks. It was acquired by Nexus Health in March 2026.
Ownership category
akta.pro rank

Where Stratis Group is headquartered

Location

Headquarters

HQ city
Palm Beach Gardens
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Stratis Group business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

  1. Strategic Consulting Services: Revenue generated from providing commercialization strategy, market access optimization, and analytics consulting services to pharmaceutical, biotechnology, and physician network clients

Go-to-market motion1 record

Distribution channels1 record

Stratis Group product offering

Product offering

Core offering

Stratis Group is a healthcare and life sciences consulting firm that delivers commercialization strategy, market access, advanced analytics, forecasting, and patient support program advisory services to pharmaceutical manufacturers, biotechnology companies, and physician networks. Engagements focus on helping clients navigate drug pricing, coverage, and patient access complexity as therapies move toward commercialization.

Product overview

Stratis Group is a healthcare consulting firm offering a portfolio of advisory services for the life sciences industry. The company provides commercialization strategy, market access optimization, advanced analytics, forecasting, and patient support program services to pharmaceutical, biotechnology, and physician network clients. Rather than a unified software platform, Stratis Group delivers these as discrete consulting service offerings focused on helping clients navigate drug pricing complexity, coverage decisions, and patient access challenges during therapy commercialization.

Differentiator

Problem solved

Functional benefit

Products and services

  • Commercialization Strategy Services Consulting services helping pharmaceutical, biotechnology, and physician network clients develop and execute go-to-market strategies for their products.
  • Market Access Services Advisory services focused on optimizing market access, reimbursement strategy, and payer negotiations for life sciences products.
  • Advanced Analytics Data analytics offerings providing insights for pharmaceutical commercialization, forecasting, and market opportunity assessment.
  • Patient Support Programs Program design and optimization services for patient support initiatives to improve therapy access and adherence.
  • Forecasting Services Market forecasting and predictive analytics services to support commercial planning and investment decisions.

Quantifiable outcome

  • Enhanced capabilities in healthcare services and market access through strategic acquisition

Companies that use Stratis Group

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Stratis Group technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Stratis Group partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • The Lockwood GroupcoreStrategic or Co-development Partner · 19 March 2026The Lockwood Group, owned by Ares Management Corporation, acquired Stratis Group through its Nexus Health subsidiary as part of a broader growth strategy to expand its commercialization and market access platform across the life sciences industry.
  • Nexus HealthcoreStrategic or Co-development Partner · 17 March 2026Nexus Health, a strategic consulting and market access firm and part of The Lockwood Group, acquired Stratis Group. The acquisition combines Stratis Group's expertise in advanced analytics, forecasting, patient support programs, and market access optimization with Nexus Health's existing capabilities in medical affairs, oncology education, and access strategy.

Scale indicators2 records

Recent moves3 records

Expansion highlights3 records

Stratis Group competitors and assessment

Company assessment

Direct peers

  • Apex Market Access: Boutique consultancy focused on market access strategy and payer engagement for pharma and biotech. Comparable to Stratis in service scope and target client profile.
  • ZS Associates: Specialist consultancy focused on pharma sales, marketing, and market access analytics. Directly comparable to Stratis in offering advanced analytics and commercialization strategy for pharmaceutical manufacturers.
  • Beghou Consulting: Boutique life sciences consultancy serving pharma and biotech on commercialization, market access, and advanced analytics. Closest direct competitor to Stratis in size, service mix, and target customer profile.
  • Precision Medicine Group: Specialized commercialization and market access services for biotech and pharma. Highly comparable to Stratis in patient support programs, market access strategy, and commercial analytics offerings.
  • Evidera: Market access, health economics, and outcomes research consultancy serving biopharma. Overlaps with Stratis's reimbursement strategy, market access, and commercialization analytics services.

Broad incumbents

  • IQVIA: Largest life sciences commercial and clinical services firm. Overlaps with Stratis in pharma market access, commercialization analytics, and forecasting, but operates at vastly greater scale across the full drug development lifecycle.
  • Syneos Health: Large CRO with a commercial solutions practice covering market access, patient support, and commercialization strategy. Broader portfolio than Stratis but directly overlapping in pharma commercialization services.
  • Deloitte (Life Sciences & Health Care): Big Four consultancy with a dedicated life sciences practice covering market access, commercial strategy, and analytics. Represents scaled-incumbent competition for boutique players like Stratis.
  • McKinsey (Pharma & Medical Products): Global strategy firm with a large pharma practice covering market access, commercial excellence, and analytics. Represents top-tier competition for Stratis's commercialization and pricing strategy engagements.

Emerging players

  • LSC Life Sciences: Life sciences consulting and analytics firm serving pharma and biotech clients. Comparable in offering strategy and analytics services to specialty pharma clients.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks6 records

Key highlights5 records

Customer concentration

Stratis Group social profiles

Digital presence

Stratis Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Stratis Group leadership team

Management profile

Number of profiles

Stratis Group funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Stratis Group M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Stratis Group

What does Stratis Group do?

Stratis Group is a healthcare and life sciences consulting firm that delivers commercialization strategy, market access, advanced analytics, forecasting, and patient support program advisory services to pharmaceutical manufacturers, biotechnology companies, and physician networks. Engagements focus on helping clients navigate drug pricing, coverage, and patient access complexity as therapies move toward commercialization.

Is Stratis Group a public or private company?

Stratis Group is a private company. It is classified as private equity controlled and is currently acquired.

When was Stratis Group founded?

Stratis Group was founded in -1. It employs 51 to 100 people.

Where is Stratis Group based?

Stratis Group is headquartered in Palm Beach Gardens, United States, in the North America region.

How does Stratis Group make money?

One revenue line is on record: strategic Consulting Services.

Who are Stratis Group's main competitors?

Direct peers on record are Apex Market Access, ZS Associates, Beghou Consulting, Precision Medicine Group and Evidera. Broad incumbents are IQVIA, Syneos Health, Deloitte (Life Sciences & Health Care) and McKinsey (Pharma & Medical Products). LSC Life Sciences is listed as an emerging player.

Does Stratis Group have an API?

No public API is recorded for Stratis Group.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireClearsight Advises Stratis Group in its Acquisition by Nexus Health, part of The Lockwood GroupClearsight Advisors served as the exclusive financial advisor to Stratis Group, LLC in its acquisition by Nexus Health, part of The Lockwood Group, LLC, a portfolio company of Ares Management Corporation. Stratis Group, a consulting firm founded in 2014 specializing in pharmaceutical and biotechnology commercialization strategy, will enhance Nexus Health's capabilities in market access, patient services, health economics, and analytics. The transaction positions the combined entity to support life sciences clients from early commercialization planning through launch and lifecycle optimization as part of Lockwood's healthcare services platform.PR NewswireNexus Health, Part of The Lockwood Group, Welcomes Stratis Group to Expand Commercialization and Market Access CapabilitiesNexus Health, a strategic consulting and market access firm and part of The Lockwood Group, announced the acquisition of Stratis Group, a consulting firm specializing in commercialization strategy, market access, patient services, HEOR, field reimbursement management, and analytics for pharmaceutical, biotechnology, and physician network clients. The acquisition strengthens Nexus Health's integrated capabilities including patient services, HEOR, RWE generation, adherence strategy, and deep quantitative analytics to support clients from early commercialization planning through launch and lifecycle optimization. Stratis Group, founded in 2014 and headquartered in Palm Beach Gardens, FL, brings advanced analytics, customer research, and market insights that complement Nexus Health's existing offerings in strategic consulting, value communications, and patient access solutions.Pulse 2.0Nexus Health: Acquisition Of Stratis Group Expands Commercialization And Market Access CapabilitiesNexus Health, a strategic consulting and market access firm and part of The Lockwood Group, has acquired Stratis Group, a consulting firm specializing in commercialization strategy, market access, and analytics for pharmaceutical, biotechnology, and physician network clients. The acquisition combines Stratis Group's expertise in advanced analytics, forecasting, patient support programs, and market access optimization with Nexus Health's existing capabilities in medical affairs, oncology education, and access strategy. The deal aligns with The Lockwood Group's broader growth strategy to expand its commercialization and market access platform across the life sciences industry.